Biotechnology company, Amgen, has appointed Robert Bradway to the company’s board of directors. Bradway is Amgen’s president and chief operating officer. He will not serve on any committees of the board.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...